Dec 04, 2023 / 01:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to DAVIO 2 top-line data conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would like now to turn the conference over to EyePoint Pharmaceuticals President and Chief Executive Officer, Dr. Jay Duker. Please go ahead.
Jay Duker - EyePoint Pharmaceuticals, Inc. - President, CEO, & Board Director
Thank you very much, and good morning, everybody. With me this morning is George Elston, our Executive Vice President and CFO. We really appreciate you joining us for this really exciting data release of our DAVIO 2 Phase 2 clinical trial top-line results.
As we may be making forward-looking statements, we need to remind you of that. And if you would like more details around the forward-looking statements, you can visit our website.
EyePoint Pharmaceuticals is a company that's dedicated to improving the lives of patients by sustained delivery of medications to the back of the eye. Our lead asset, which you are going to hear about
EyePoint Pharmaceuticals Inc Conference call to discuss topline results Transcript
Dec 04, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers